Cambridge Nutritional Sciences (CNSL) Competitors GBX 3.53 -0.22 (-5.87%) As of 12:39 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock CNSL vs. CEL, OTT, BCE, FOX, CZN, CHT, DVW, BRCI, NPT, and RCIShould you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Oxford Technology 3 Venture Capital Trust (OTT), Beacon Energy (BCE), Fox Marble (FOX), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry. Cambridge Nutritional Sciences vs. Its Competitors Celadon Pharmaceuticals Oxford Technology 3 Venture Capital Trust Beacon Energy Fox Marble Curzon Energy 290005 (CHT.L) 5008 (DVW.L) BlackRock Comms Income Inv Tst NetPlay TV RapidCloud International Cambridge Nutritional Sciences (LON:CNSL) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Does the media prefer CNSL or CEL? In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score. Company Overall Sentiment Cambridge Nutritional Sciences Neutral Celadon Pharmaceuticals Neutral Which has more volatility and risk, CNSL or CEL? Cambridge Nutritional Sciences has a beta of 3.89, meaning that its share price is 289% more volatile than the S&P 500. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, meaning that its share price is 126% less volatile than the S&P 500. Do insiders & institutionals hold more shares of CNSL or CEL? 10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. 10.9% of Cambridge Nutritional Sciences shares are held by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is CNSL or CEL more profitable? Cambridge Nutritional Sciences has a net margin of -3.36% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Cambridge Nutritional Sciences-3.36% -3.34% -2.36% Celadon Pharmaceuticals -4,024.62%-187.26%-34.40% Which has higher earnings and valuation, CNSL or CEL? Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCambridge Nutritional Sciences£9.77M0.86-£3.03MN/AN/ACeladon Pharmaceuticals£123.38K66.61-£4.97M-£7.98-1.68 SummaryCambridge Nutritional Sciences beats Celadon Pharmaceuticals on 6 of the 10 factors compared between the two stocks. Get Cambridge Nutritional Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter. Email Address CNSL vs. The Competition Export to ExcelMetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON ExchangeMarket Cap£8.40M£3.41B£5.72B£3.02BDividend YieldN/A1.99%4.60%5.02%P/E Ratio-362.1018.1628.07160.81Price / Sales0.86360.27462.58278,114.25Price / CashN/A146.5436.5527.97Price / Book0.882.498.644.69Net Income-£3.03M£99.80M£3.24B£5.90B7 Day Performance-2.84%-0.83%4.08%0.28%1 Month Performance-2.49%-1.62%10.68%8.61%1 Year Performance-2.38%117.53%34.47%78.50% Cambridge Nutritional Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNSLCambridge Nutritional SciencesN/AGBX 3.53-5.9%N/A-8.7%£8.40M£9.77M-362.103,200Gap UpCELCeladon PharmaceuticalsN/AGBX 13.40flatN/AN/A£8.22M£123.38K-1.682,780OTTOxford Technology 3 Venture Capital TrustN/AN/AN/AN/A£2.13M-£85K-12.59203Gap DownBCEBeacon EnergyN/AGBX 0flatN/AN/A£740KN/A-0.3544,600FOXFox MarbleN/AGBX 0.04-7.0%N/A-97.1%£167K£722.06K-135.0010,600Gap DownCZNCurzon EnergyN/AN/AN/AN/A£34KN/A-3.4014,700Gap DownCHT290005 (CHT.L)N/AN/AN/AN/A£0.00N/A0.0020,300DVW5008 (DVW.L)N/AN/AN/AN/A£0.00N/A0.00N/AGap UpBRCIBlackRock Comms Income Inv TstN/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading VolumeNPTNetPlay TVN/AN/AN/AN/A£0.00N/A0.00147,000RCIRapidCloud InternationalN/AN/AN/AN/A£0.00N/A0.0023,000 Related Companies and Tools Related Companies Celadon Pharmaceuticals Competitors Oxford Technology 3 Venture Capital Trust Competitors Beacon Energy Competitors Fox Marble Competitors Curzon Energy Competitors 290005 (CHT.L) Competitors 5008 (DVW.L) Competitors BlackRock Comms Income Inv Tst Competitors NetPlay TV Competitors RapidCloud International Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CNSL) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
